Search

IMMUSANT GOES ON HIRING SPREE AHEAD OF PHASE 2 CELIAC VACCINE TRIAL

ImmusanT is boosting its senior staff, bringing on Daiichi Sankyo's SVP for internal medicine therapeutics, Ken Truitt, as its new...

NABRIVA LINES UP FDA FILING AFTER ANTIBIOTIC CLEARS SECOND PIVOTAL TEST

A second phase 3 trial of Nabriva Therapeutics' lefamulin has hit its primary endpoint. The positive readout further burnishes the...

 
 
 

ALLERGY THERAPEUTICS SHOWS DOSE RESPONSE IN MIDPHASE TRIAL, SETTING STAGE FOR PIVOTAL PROGRAM

A phase 2 trial of Allergy Therapeutics' grass pollen candidate met its primary endpoint of showing a dose-response relationship. With...

 
 
 
From truffle-hunting to tulips, serving up the very best river cruises for you

FROM TRUFFLE-HUNTING TO TULIPS, SERVING UP THE VERY BEST RIVER CRUISES FOR YOU

When it comes to river cruises, now is the time to book for this year and next. The Mail on Sunday's Caroline Hendrie presents a host...

 
 
 
Passengers on 'cruises from hell' tell of near-death experiences including fires and 30ft waves

PASSENGERS ON 'CRUISES FROM HELL' TELL OF NEAR-DEATH EXPERIENCES INCLUDING FIRES AND 30FT WAVES

Channel 4's Cruises from Hell: Caught on Camera, shows passengers nearly dying on hellish voyages. It'll discuss the 2014 Anek Line...

 
 
 
BioAffinity Seeking $5M for Cancer Diagnostic, Adds Board Member

BIOAFFINITY SEEKING $5M FOR CANCER DIAGNOSTIC, ADDS BOARD MEMBER

San Antonoio - BioAffinity, the maker of a cancer diagnostic test, has added Peter Knight, who was the chief of staff for Al Gore when...

 
 
 
Celsius Snags $65M to Harness Single-Cell Genomics for Drug Discovery

CELSIUS SNAGS $65M TO HARNESS SINGLE-CELL GENOMICS FOR DRUG DISCOVERY

With biotech flush with venture capital funding, it seems that every hot new area of biology research now comes with its own startup....

A startup that wants to make treatments that edit single letters in our DNA just raised $87 million

A STARTUP THAT WANTS TO MAKE TREATMENTS THAT EDIT SINGLE LETTERS IN OUR DNA JUST RAISED $87 MILLION

Beam Therapeutics, a new startup co-founded by gene-editing pioneers, just raised $87 million to get its technology that changes single...

 
 
 

BIOSYNTHESIS OF ANGELYL-COA IN SACCHAROMYCES CEREVISIAE

The angelic acid moiety represents an essential modification in many biologically active products. These products are commonly known...

Evelo IPO Raises $85M for Microbiome Drugs in Inflammation, Cancer

EVELO IPO RAISES $85M FOR MICROBIOME DRUGS IN INFLAMMATION, CANCER

Evelo Biosciences now has $85 million to spend on its pipeline of drugs that target the human microbiome. The Cambridge, MA-based biotech...

 
 
 
 
 
 
New Approach for Treating Neuropathic Pain Discovered

NEW APPROACH FOR TREATING NEUROPATHIC PAIN DISCOVERED

Novel therapeutic that appears to interrupt the signaling cascades in the body required for multiple forms of neuropathic pain identified.

 
 
 

UNIVERSAL EVOLUTIONARY SELECTION FOR HIGH DIMENSIONAL SILENT PATTERNS OF INFORMATION HIDDEN IN THE REDUNDANCY OF VIRAL GENETIC CODE

AbstractMotivationUnderstanding how viruses co-evolve with their hosts and adapt various genomic level strategies in order to ensure...

New CRISPR Startup from Feng Zhang Revealed

NEW CRISPR STARTUP FROM FENG ZHANG REVEALED

With all the buzz this week about the new CRISPR diagnostic startup from the University of California, Berkeley lab of Jennifer Doudna,...